Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Dyne Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 94 | 2 | 90 | −2 |
| Shares | 47.7M | 13.7K | 46.7M | −1.03M (−2.2%) |
| Value | $456.6M | $132.0K | $320.7M | −$135.8M (−29.7%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Dyne Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 227,358 | $1.56M | 0.02% |
| Balyasny Asset Management LLC | 98,866 | $679.0K | 0.00% |
| Bank of Montreal | 41,304 | $290.0K | 0.00% |
| Cornercap Investment Counsel Inc | 27,651 | $190.0K | 0.03% |
| Algert Global LLC | 18,555 | $127.0K | 0.01% |
| Bridgeway Capital Management, LLC | 16,400 | $113.0K | 0.00% |
| SG Americas Securities, LLC | 10,751 | $74.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 610 | $4.00K | 0.00% |
| Simplex Trading, LLC | 37 | $0 | 0.00% |
Sold out (11)
Institutions that held Dyne Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Norges Bank | 600,000 | $5.78M |
| Octagon Capital Advisors LP | 525,284 | $5.06M |
| Commodore Capital LP | 305,125 | $2.94M |
| State of Wisconsin Investment Board | 38,900 | $375.0K |
| Two Sigma Investments, LP | 26,722 | $258.0K |
| Nan Fung Group Holdings Ltd | 11,629 | $112.0K |
| ProShare Advisors LLC | 10,966 | $105.0K |
| US Bancorp | 407 | $4.00K |
| Lindbrook Capital, LLC | 437 | $4.00K |
| Signaturefd, LLC | 71 | $1.00K |
| Toronto Dominion Bank | 3 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held Dyne Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 10,113 | $97.0K |
| Amalgamated Financial Corp. | 3,631 | $35.0K |